Garry E. Menzel - 05 Jun 2024 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
Director
Signature
/s/ Jonathan Allan, Attorney-in-Fact
Issuer symbol
STOK
Transactions as of
05 Jun 2024
Net transactions value
$0
Form type
4
Filing time
07 Jun 2024, 16:21:31 UTC
Previous filing
10 Jul 2023
Next filing
06 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Director Stock Option (Right to Buy) Award $0 +7,639 $0.000000 7,639 05 Jun 2024 Common Stock 7,639 $16.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest in full on the earlier of: (i) June 5, 2025 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date.